| Literature DB >> 31324025 |
Isaac Benito-González1, Amparo López-Rubio1, Antonio Martínez-Abad2, Ana-Rosa Ballester3, Irene Falcó1,4, Luis González-Candelas3, Gloria Sánchez1, Jesús Lozano-Sánchez5,6, Isabel Borrás-Linares5, Antonio Segura-Carretero5,7, Marta Martínez-Sanz8.
Abstract
Posidonia oceanica waste biomass has been valorised to produce extracts by means of different methodologies and their bioactive properties have been evaluated. Water-based extracts were produced using ultrasound-assisted and hot water methods and classified according to their ethanol-affinity (E1: ethanol soluble; E2: non-soluble). Moreover, a conventional protocol with organic solvents was applied, yielding E3 extracts. Compositional and structural characterization confirmed that while E1 and E3 extracts were mainly composed of minerals and lipids, respectively, E2 extracts were a mixture of minerals, proteins and carbohydrates. All the extracts showed remarkably high antioxidant capacity, which was not only related to phenolic compounds but also to the presence of proteins and polysaccharides. All E2 and E3 extracts inhibited the growth of several foodborne fungi, while only E3 extracts decreased substantially the infectivity of feline calicivirus and murine norovirus. These results show the potential of P. oceanica waste biomass for the production of bioactive extracts.Entities:
Keywords: antifungal activity; antioxidant capacity; antiviral; hot water extraction; ultrasound; valorisation
Mesh:
Substances:
Year: 2019 PMID: 31324025 PMCID: PMC6669500 DOI: 10.3390/md17070409
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Total carbohydrate, protein, lipid and phenolic content and antioxidant capacity of the extracts, evaluated by the ABTS and β-carotene bleaching methods. Different letters within the same column denote significant differences between extracts (p ≤ 0.05).
| Extract | Carbohydrate Content (mg/g Extract) | Protein Content (mg BSA/g Extract) | Lipid Content (mg/g Extract) | Total Phenolics (mg GAE/g Extract) | Ash Content (mg/g Extract) | TEAC | % β-Carotene Bleaching Inhibition † |
|---|---|---|---|---|---|---|---|
|
| 12.2 ± 2.9 c | 58.4 ± 3.2 d | n.d. | 7.6 ± 2.2 c | 751.5 ± 1.4 a | 275.9 ± 10.2 c,d | 57.0 ± 2.3 c |
|
| 12.9 ± 2.4 c | 70.9 ± 1.4 c | n.d. | 37.9 ± 8.0 b | 723.1 ± 6.6 b | 236.5 ± 16.5 e | 45.0 ± 1.8 d |
|
| 117.7 ± 18.5 b | 269.3 ± 5.5 b | n.d. | 48.7 ± 5.5 b | 413.3 ± 8.8 c | 346.7 ± 5.6 b | 68.7 ± 4.2 b |
|
| 287.1 ± 2.5 a | 363.0 ± 1.9 a | n.d. | 90.2 ± 17.6 a | 339.1 ± 9.5 d | 730.0 ± 12.2 a | 65.5 ± 5.3 b |
|
| - | - | 785.3 ± 73.5 a | 79.6 ± 23.1 a | 180.7 ± 3.6 e | 211.2 ± 51.2 d,e | 70.8 ± 2.6 b |
|
| - | - | 560.3 ± 85.3 b | 76.2 ± 3.3 a | 347.5 ± 22.9 d | 443.8 ± 150.2 b,c | 82.8 ± 3.5 a |
* TEAC values were calculated after 30 min. † Calculated for the extracts at a concentration of 0.5 mg/mL.
Figure 1Carbohydrate composition of the aqueous P. oceanica extracts. (A) Absolute concentration values for E1 and E2 extracts and (B) their relative abundance in the E2 extracts. Different letters denote significant monosaccharide content differences between extracts (p ≤ 0.05).
Figure 2FT-IR spectra of the different P. oceanica extracts obtained by means of water-based extractions (A,B) and organic solvent-based extractions (C). E1 US, E2 US and E3 US spectra have been offset for clarity.
Figure 3XRD patterns of the freeze-dried extracts. (A,B) Water-soluble extracts and (C) organic-soluble extracts. The spectra from E1 US and E2 US have been offset for clarity.
Summary of the antifungal activity showed by all the different extracts tested in the following microorganisms at 3 and 7 dpi at their highest concentration (5 mg/mL). Antifungal activity was shown as the reduction in the diameter ± SD (%).
|
|
|
|
|
|
|
|
|
| ||||||
|
|
|
| 37 ± 9 | 12 ± 3 | 46 ± 2 | 14 ± 4 |
|
|
|
| - | - | 40 ± 2 | 24 ± 2 |
|
|
|
| - | - | −(42 ± 3) a | −(27 ± 3) a |
|
|
|
| 41 ± 12 | 19 ± 8 | 100 | 100 |
|
|
|
| - | - | - | - |
|
|
|
| - | - | −(100) a | −(90 ± 4) a |
|
| ||||||
|
|
|
| 24 ± 8 | 12 ± 4 | - | - |
|
|
|
| - | - | 15 ± 3 b | − b |
|
|
|
| - | - | −(22 ± 3) a | −(19 ± 2) a |
|
|
|
| - | - | 61 ± 4 | 69 ± 5 |
|
|
|
| - | - | - | - |
|
|
|
| - | - | −(100) a | −(70 ± 11) a |
a Numbers between brackets show the % reduction in the sporulation. b With remarkable reduction in the hypha’s development (Figure S3-D).
Figure 4Reduction of (A) feline calicivirus (FCV) titres (log TCID50/mL) and (B) murine norovirus (MNV) titres (log TCID50/mL) treated with P. oceanica extracts at different concentrations (0.5 or 0.05%) after 25 °C and 37 °C ON incubations, respectively. * Each bar represents the average of triplicates. Within each column, different letters denote significant differences between treatments. ** Horizontal line depicts the detection limit.
Sample codes for the different P. oceanica extracts.
| Sample Code | Pre-Treatment | Extraction Method | Solvent | Fraction (Ethanol Precipitation) |
|---|---|---|---|---|
|
| - | Ultrasound | Water | Supernatant |
|
| - | Heating | Water | Supernatant |
|
| - | Ultrasound | Water | Precipitate |
|
| - | Heating | Water | Precipitate |
|
| Ultrasound | Soxhlet | Toluene:ethanol | - |
|
| Heating | Soxhlet | Toluene:ethanol | - |